Skip to content
Black Week: 20% off everything, code BLACK

Search

What are you looking for?

Type at least 2 characters to see suggestions.

Cortagen 20mg
Cortagen 20mg

Cortagen 20mg

Cortagen 20 mg in the vial (lyophilisate) is a synthetic short regulatory peptide from the family of tissue-specific bioregulators of the Khavinson school (Cytogen line), traditionally associated with the tetrapeptide Ala-Glu-Asp-Pro (AEDP) and assigned to the cerebral cortex and neuron. Research context: peptide bioregulation of the nerve cell – neuroprotection, neuroregeneration, antioxidant effect and impact on cognitive functions. Research Use Only reagent

52,99 €
With code BLACK: 42,39 € Lowest price in the 30 days before the discount: 52,99 €
Buy more, pay less
Fast shipping
Free delivery from 350 €
Returns policy
View the laboratory analysis report Peptide Calculator

Cortagen 20 mg - bioregulator peptide, research reagent

  • Cortagen: short bioregulatory peptide from the Cytogen line.
  • 20 mg lyophilisate in a vial.
  • Research Use Only reagent, not a substitute for Cortexin.

Product status information

Chemical reagent intended exclusively for laboratory tests (Research Use Only). It is not a medicinal product, dietary supplement or food. It is not intended for use on humans or animals. Sales only to registered research units and laboratories.

Regulatory status (critical)

As a research reagent, Cortagen has never been registered as a medicinal product in the EU, US or other jurisdiction. It should be clearly distinguished from Cortexin — a peptide preparation registered as a medicine in Russia (and selected countries in the region), used in neurology. Cortexin is a registered medicinal product in a specific jurisdiction; Cortagen in the reagent trade is a Research Use Only material and is not a substitute for the medicinal product.

No EMA/FDA authorization as a medicine and no EFSA authorization as a dietary supplement ingredient. Marketing the product as a “brain peptide”, a “neuroprotective agent for athletes” or “memory support” is contrary to the Research Use Only framework.

Cortagen is a synthetic short regulatory peptide derived from the concept peptide bioregulation developed in St. Petersburg Institute of Bioregulation and Gerontology under the supervision of Vladimir Khavinson. In this research school, Cortagen belongs to the family of tissue-specific regulatory peptides (Cytogen line, nomenclature ending in “-gen”), traditionally linked to a tetrapeptide with the sequence Ala-Glu-Asp-Pro (AEDP).

The conceptual assumption of the entire group is that short, several-amino-acid peptides have affinity for the tissue from which they were originally isolated or to which their design concerns – in the case of Cortagen, this is the cerebral cortex and neuron. Cortagen fits into the trend of research on peptide regulation of aging (peptide bioregulation of aging), which has been developed mainly by the Russian scientific school since the 1980s.

The central hypothesis of this school is the modulation of gene expression by direct or indirect interaction of short peptides with specific DNA sequences, leading to the regulation of proliferation, differentiation and functions of cells of a given tissue type. Unlike signal peptides acting through membrane receptors, bioregulatory peptides of this family are considered primarily as hypothetical modulators of transcription – a concept that remains a matter of debate and requires independent replication outside the originating research centres.

In the Pro-Body catalog Cortagen belongs to a group peptides on brain function studied in the context of nerve cell function. This reagent is supplied as 20 mg lyophilisate in a vial, for reconstitution with bacteriostatic water in laboratory conditions. The freeze-dried form ensures stability of the peptide before dissolution and allows researchers to prepare working concentrations tailored to the experimental design. Purity verified by HPLC ≥98%, identity confirmed by mass spectrometry, COA available for each batch.

Peptide bioregulation in the Khavinson school

Cortagen takes the place of a peptide in this family tissue-specific for the cerebral cortex and neuron — tools to study the concept of peptide bioregulation of the nerve cell, its protection, neuroregeneration and resistance to metabolic stress in experimental models. In the same line of organ bioregulators, the literature of the bioregulation school also considers peptides assigned to other tissues – from cardiac peptide Cardiogen after bronchial peptide Bronchogen — and for Cortagen itself, the literature also mentions Cortexin, a product with registered medicinal status in Russia, which should not be confused with a research reagent (a distinction discussed below).

What is Cortagen?

Chemically, Cortagen is traditionally associated with a linear tetrapeptide with the sequence Ala-Glu-Asp-Pro.

  • Common name: Cortagen, cortical/brain bioregulator peptide, cortical peptide
  • Sequence (traditionally assigned): Ala-Glu-Asp-Pro (AEDP) – alanyl-glutamyl-asparaginyl-proline; sequence for verification in the batch COA
  • Chemical class: synthetic short regulatory peptide (tetrapeptide); family of bioregulator peptides of the Khavinson school, tissue-specific lineage for the cerebral cortex/neuron
  • CAS number: for verification in the batch COA
  • Molar mass: dependent on confirmed sequence; for the AEDP variant of approximately 430 g/mol (indicative value – the mass from the MS analysis of the batch is binding)
  • Supplied form: lyophilisate 20 mg in a vial, for reconstitution with bacteriostatic water; purity ≥98% HPLC
  • Conceptual origin: Khavinson’s concept of peptide bioregulation (St. Petersburg Institute of Bioregulation and Gerontology); Cytogen line; medicinal equivalent: Cortexin (registered drug in Russia)

Origin: Cortagen comes from the tissue-specific peptide research program conducted at St. Petersburg Institute of Bioregulation and Gerontology. As part of this program, peptides were designed as short regulatory fragments assigned to specific organs, and then their effect on cells of a given tissue was examined in cultures and in animal models. Cortagen was assigned to the cerebral cortex and neuron.

It should be emphasized that the exact sequence and chemical identity of peptides of this family in the reagent trade may be inconsistent – therefore the sequence and molar mass of each batch of Cortagen require confirmation in a certificate of analysis (COA), and the AEDP sequence is given as traditionally assigned, not as an unconditionally established identity of each material on the market.

SCIENTIFIC PERSPECTIVE

Most data on Cortagen and related bioregulatory peptides come from cell models (neuron cultures, tissue cultures of nervous tissue) and animal models, published mainly by centers of the Russian school of bioregulation.

Observations regarding neuroprotection, neuroregeneration and effects on cognitive functions require interpretation in the context of the research model and limited independent replication outside home centers. Extrapolation to human clinical applications is not valid – there are no large, randomized clinical trials, and the chemical sequence requires analytical confirmation on a batch-by-batch basis.

Mechanism of action at the molecular level

Cortagen is considered in the literature through the prism of the concept of tissue-specific peptide bioregulation. The following description refers to hypotheses and observations from preclinical models – not to a validated human clinical mechanism. Profile observed and postulated in preclinical models:

  1. Tissue-specific peptide bioregulation of the neuron — the central hypothesis of the Khavinson school assumes that short regulatory peptides enter the cell and modulate gene expression by interacting with specific DNA sequences or with the transcription apparatus. In the case of Cortagen, this concerns genes important for the function, survival and differentiation of cerebral cortex cells. Mechanism: postulated transcription modulation, not classic membrane receptor stimulation (Khavinson 2002; Khavinson et al. 2021)
  2. Modulation of neuroregeneration and neuronal protection — the influence of peptides of this family on the survival of neurons, regrowth of processes and protection against apoptosis was studied in tissue culture models and in models of neural tissue damage; for Cortagen, the research context is neuroprotection and renewal of cerebral cortex cells in experimental conditions (Kuznik et al. 2008)
  3. Antioxidant and anti-inflammatory effects — the protective potential of the peptide against cellular damage was tested in models of nervous tissue subjected to oxidative stress or hypoxia; the research context includes the protection of the neuron against reactive oxygen species and the modulation of inflammatory markers in neural tissue
  4. Modulation of cognitive functions and neuroplasticity — postulated impact on parameters related to synaptic plasticity and cognitive processes, considered in animal models as part of the general concept of bioregulation of nervous tissue

Characteristics of peptides of this family (based on the literature of the bioregulation school):

  • Short sequence (tetrapeptide) and low molecular weight – typical for the designed regulatory fragments
  • Postulated ability to penetrate the cell and interact at the nuclear level – a hypothesis requiring further mechanistic verification
  • The action is described as modulatory and contextual, rather than classically stimulating – the peptide is intended to “normalize” cell function, not to force a one-way response
  • Human pharmacokinetic profile: not characterized for the reagent; no data from randomized clinical trials

In cellular and animal models, peptides of this family have been tested for their effects on neuronal viability, cell renewal parameters, and markers of oxidative stress and inflammation – a phenotype interpreted by the authors as tissue-specific bioregulation of the cerebral cortex. These observations should be treated as preliminary and require independent confirmation.

Applications in scientific research

Cortagen is used as a reagent in research work on the concept of peptide bioregulation of tissue-specific nervous tissue. In vitro models (neuron cultures, tissue cultures of nervous tissue, models of oxidative stress, hypoxia and excitotoxicity) examine its impact on cell viability, neuroregeneration, differentiation and markers of oxidative damage and inflammation. In vivo models (animal models used by bioregulation centers) examined the influence of peptides of this family on tissue parameters related to neuroprotection, regeneration and aging of nervous tissue. Specific research directions include:

  • The concept of peptide tissue bioregulation — Cortagen as a model tissue-specific peptide for the cerebral cortex; research on the hypothesis of modulation of gene expression by short peptides in nerve cells
  • Neuroprotection models — assessment of the protective potential against oxidative stress, hypoxia and excitotoxicity in neuronal cultures
  • Neuroregeneration and plasticity studies — the effect of the peptide on cell renewal parameters, sprout regrowth and neuroplasticity markers in breeding models
  • Experimental gerontology — bioregulatory peptides as tools for studying processes related to the aging of nervous tissue (Anisimov, Khavinson 2010)
  • Independent and methodological verification — replication of observations of the bioregulation school in independent laboratories, including confirmation of the chemical identity and sequence of the tested material

For researchers designing comparative series within the same family of bioregulators, form and organ variants are also available – intranasal Cortagen spray as an alternative form of the same cortical peptide and the related pineal longevity peptide Epithalon 10mg, described in the same concept of bioregulation of aging.

Storage conditions

  • Lyophilisate: temperature 2-8°C, protected from light and moisture; for long-term storage –20°C
  • Stability of the lyophilisate: retains integrity for the period specified in the batch COA if stored under refrigerated conditions
  • Working solution after reconstitution: storage at 2–8°C for short-term use; aliquots at –20°C / –80°C for longer storage
  • Avoid repeated cycles of freezing and thawing the solution – they degrade the peptide structure
  • Sensitivity to moisture – hygroscopic lyophilisate; minimize exposure time of an open vial to air
  • Keep out of the reach of unauthorized persons – laboratory material, not intended for consumer sale

Summary

Cortagen (traditionally linked to the tetrapeptide Ala-Glu-Asp-Pro, AEDP) is a synthetic short regulatory peptide from the family of tissue-specific bioregulators developed at the Vladimir Khavinson school (St. Petersburg Institute of Bioregulation and Gerontology), Cytogen line. It is attributed to the cerebral cortex and neuron, and the conceptual assumption is the modulation of neuronal cell gene expression by a short peptide – a hypothesis with four main themes: tissue-specific bioregulation of the neuron, modulation of neuroregeneration and neuronal protection, antioxidant/anti-inflammatory effects in neural tissue models, and modulation of cognitive function and neuroplasticity.

The whole concept remains mainly developed by the Russian school of science and is characterized by limited independent replication – data comes from cellular and animal models, without large randomized clinical trials. Cortagen research reagent must be distinguished from the drug Cortexin, registered in Russia – are two different regulatory entities. Lyophilized form: 20 mg in a vial, reconstitution with bacteriostatic water, HPLC purity ≥98%, MS confirmation with sequence verification, COA for each batch.

Regulatory Status – Research Use Only; no registration of the reagent as a medicine; WADA status: class S0 (non-approved substances), prohibited at all times. The sequence of each batch requires confirmation with the COA.

Bibliography

  1. Khavinson VKh (2002). Peptides and Aging. PubMed
  2. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR (2021). Peptide Regulation of Gene Expression: A Systematic Review. PubMed
  3. Kuznik BI, Pateiuk AV, Baranchugova LM, Rusaeva NS (2008). Effects of epithalon and cortagen on immunity and hemostasis in neonatally hypophysectomized chicken and old birds. PubMed
  4. Anisimov VN, Khavinson VKh (2010). Peptide bioregulation of aging: results and prospects. PubMed
  5. Chalisova NI, Zachepilo TG, Kamyshev NG, Lopatina NG (2015). The regulating effect of dipeptides on cell proliferation in nerve tissue culture in mammals and on associative learning in insects. PubMed